Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM
· Real-Time Price · USD
22.97
-0.12 (-0.52%)
At close: Sep 26, 2025, 3:59 PM
23.10
0.57%
After-hours: Sep 26, 2025, 07:54 PM EDT
Beam Therapeutics Revenue Breakdown
| Period Ending | Jun 30, 2011 |
|---|---|
| Home And Security Revenue | 889.7M |
| Home And Security Revenue Growth | n/a |
| Spirits Revenue | 702.7M |
| Spirits Revenue Growth | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific South America Revenue | 127M | 99.7M | 110.3M | 108.1M | 140.8M | 130.9M | 113.7M | 117.2M | 487.4M |
| Asia Pacific South America Revenue Growth | +27.38% | -9.61% | +2.04% | -23.22% | +7.56% | +15.13% | -2.99% | -75.95% | n/a |
| E M E A Revenue | 198.9M | 124.5M | 116.9M | 364M | 391.1M | 380.1M | 370.1M | 309.3M | 1.27B |
| E M E A Revenue Growth | +59.76% | +6.50% | -67.88% | -6.93% | +2.89% | +2.70% | +19.66% | -75.67% | n/a |
| North America Revenue | 413.6M | 374.5M | 410.4M | n/a | n/a | n/a | n/a | n/a | n/a |
| North America Revenue Growth | +10.44% | -8.75% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 21.32M | 27.94M | 28.66M | 26.52M | 24.05M | 21.29M | 37.9M | 25.41M | 24.66M | 23.49M | 22.68M | 21.82M | 24.06M | 19.25M | 17.77M | 15.77M | 13.4M | 10.27M | 8.35M | 7.5M | 6.94M | 6.81M | 6.16M | 5.49M | 4.98M | 3.93M | 3.71M | 2.83M | 2.66M | 2.66M |
| Selling, General, and Administrative Revenue Growth | -23.69% | -2.51% | +8.09% | +10.25% | +12.95% | -43.81% | +49.13% | +3.06% | +4.96% | +3.57% | +3.97% | -9.34% | +25.02% | +8.30% | +12.67% | +17.69% | +30.47% | +22.97% | +11.36% | +8.14% | +1.83% | +10.58% | +12.27% | +10.25% | +26.67% | +5.87% | +30.95% | +6.48% | 0.00% | n/a |
| Research and Development Revenue | 101.76M | 98.82M | 101.44M | 94.26M | 87.04M | 84.82M | 140.08M | 100.05M | 97.61M | 99.65M | 86.34M | 85.29M | 74.56M | 65.41M | 96.78M | 54.62M | 45.58M | 190.11M | 32.45M | 29.82M | 19.35M | 21.55M | 20.22M | 12.54M | 12.68M | 9.18M | 9.85M | 9.85M | 7.08M | 7.08M |
| Research and Development Revenue Growth | +2.98% | -2.59% | +7.62% | +8.29% | +2.62% | -39.45% | +40.01% | +2.50% | -2.05% | +15.41% | +1.24% | +14.39% | +13.98% | -32.41% | +77.18% | +19.85% | -76.03% | +485.82% | +8.80% | +54.10% | -10.19% | +6.59% | +61.18% | -1.08% | +38.14% | -6.83% | -0.02% | +39.11% | 0.00% | n/a |